<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0413066</journal-id>
<journal-id journal-id-type="pubmed-jr-id">2830</journal-id>
<journal-id journal-id-type="nlm-ta">Cell</journal-id>
<journal-id journal-id-type="iso-abbrev">Cell</journal-id>
<journal-title-group>
<journal-title>Cell</journal-title>
</journal-title-group>
<issn pub-type="ppub">0092-8674</issn>
<issn pub-type="epub">1097-4172</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26451481</article-id>
<article-id pub-id-type="pmc">4600128</article-id>
<article-id pub-id-type="doi">10.1016/j.cell.2015.09.041</article-id>
<article-id pub-id-type="manuscript">NIHMS726133</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Pausing on Polyribosomes: Make Way for Elongation in Translational Control</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Richter</surname>
<given-names>Joel D.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Coller</surname>
<given-names>Jeff</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605 USA</aff>
<aff id="A2"><label>2</label>Center for RNA Molecular Biology, Case Western Reserve University, Cleveland, OH 44106 USA</aff>
<author-notes>
<corresp id="FN1">Correspondence: <email>joel.richter@umassmed.edu</email> or <email>jmc71@case.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>29</day>
<month>9</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub">
<day>8</day>
<month>10</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>08</day>
<month>10</month>
<year>2016</year>
</pub-date>
<volume>163</volume>
<issue>2</issue>
<fpage>292</fpage>
<lpage>300</lpage>
<!--elocation-id from pubmed: 10.1016/j.cell.2015.09.041-->
<abstract>
<p id="P2">Among the three phases of mRNA translation - initiation, elongation, and termination - initiation has traditionally been considered to be rate-limiting and thus the focus of regulation. Emerging evidence, however, demonstrates that control of ribosome translocation (polypeptide elongation) can also be regulatory, and indeed exerts a profound influence on development, neurologic disease, and cell stress. The correspondence of mRNA codon usage and the relative abundance of their cognate tRNAs is equally important for mediating the rate of polypeptide elongation. Here, we discuss recent results showing that ribosome pausing is a widely used mechanism for controlling translation and as a result, biological transitions in health and disease.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>